Neoantigens are recently developed antigens that have not been detected by the immune system historically. Alterations in tumor proteins may result in the development of neoantigens caused by mutations or viral proteins. Neoantigens are used in selective treatments for cancerous cells.
Top Companies Analysis-

Achilles Therapeutics plc
Advaxis, Inc.
Frame Cancer Therapeutics
Genocea, Gradalis, Inc.
Gritstone Oncology
Immunicum AB
Medigene AG
Ziopharm Oncology, Inc.
Moderna, Inc.

Developments in biotechnology have led to rise in acceptance for immunotherapy, further driving its use in personalized medicines. Immunotherapy is widely used to treat cancer; a few the immunotherapy procedures involve the use of neoantigens, the antigens present on the surface of cancer cells. Therefore, applications of neoantigens are being widely studied to treat cancer. The uniqueness of neoantigens allows researchers to identify patients’ immune system and find antigens to target cancer cells without disturbing healthy cells.

The report analyses these key players in the global Neoantigens Industry. These players have incorporated various strategies such as expansion, new product launches, partnerships, and others to increase their Industry penetration and strengthen their position in the industry. The report is helpful in assessing the operating segments, their business performance & product portfolio, and so on.

Leading Industry players and manufacturers are studied to help give a brief idea about them in the report. The challenges faced by them and the reasons they are on that position are explained to help make a well informed decision. Competitive landscape of Neoantigens Industry is given presenting detailed insights into the company profiles, developments, merges, acquisitions, economic status and best SWOT analysis.

The report is inclusive of product type outlook, application spectrum, end-use outlook, technology landscape, regional market analysis, and competitive overview.

Market Segments-

Treatment-Based Insights
Based on treatment, the neoantigens market is segmented into combination therapy and mono therapy. In 2023, the combination therapy segment is estimated to have a larger share of the market. However, the mono therapy segment is expected to have a faster growth during the forecast period.

Therapeutic Specialty -Based Insights
Based on therapeutic specialty, the neoantigens market is segmented into gastrointestinal cancer, lung cancer, solid tumor, urinary systems cancers, melanoma, head and neck cancer, and others. In 2023, the gastrointestinal cancer segment is estimated to hold the largest share of the market and is expected to grow at the fastest rate in the coming years.

Geographic Segment Covered in the Report:

The Neoantigens Market report provides information about the market area, which is further subdivided into sub-regions and countries/regions. In addition to the market share in each country and sub-region, this chapter of this report also contains information on profit opportunities. This chapter of the report mentions the market share and growth rate of each region, country, and sub-region during the estimated period. The report also provides exhaustive PEST analysis for all five regions namely; North America, Europe, APAC, MEA and South & Central America after evaluating political, economic, social and technological factors effecting the Neoantigens market in these regions.

TABLE OF CONTENTS

1. Introduction
2. Key Takeaways
3. Research Methodology
4. Neoantigens Market Landscape
5. Neoantigens Market - Key Market Dynamics
6. Neoantigens Market - Global Market Analysis
7. Neoantigens Market - Revenue And Forecasts To 2028 - Type
8. Neoantigens Market - Revenue And Forecasts To 2028 - Application
9. Neoantigens Market Revenue And Forecasts To 2028 - Geographical Analysis
10. Industry Landscape
11. Neoantigens Market, Key Company Profiles
12. Appendix

About Us:                    

The Insight Partners is a one stop industry research provider of actionable intelligence. We help our clients in getting solutions to their research requirements through our syndicated and consulting research services. We specialize in industries such as Semiconductor and Electronics, Aerospace and Defense, Automotive and Transportation, Biotechnology, Healthcare IT, Manufacturing and Construction, Medical Device, Technology, Media and Telecommunications, and Chemicals

Contact Us:                        

If you have any queries about this report or if you would like further information, please

Contact Person: Sameer Joshi

E-mail: sales@theinsightpartners.com

Phone: +1-646-491-9876